Stay updated with breaking news from Peter Bains. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kedar Upadhye has been appointed as the new Chief Financial Officer (CFO) of Biocon Biologics while current CFO, M.B. Chinappa will take on a strategic finance role at Biocon Group. These leadership changes will be effective October 31, stated ...
Biocon announced that its Board of Directors has approved the appointment of Peter Bains as Group CEO,...
Upadhye will be replace current CFO MB Chinappa who will take up strategic finance role at Biocon Group and will work with Peter Bains, the recently appointed Group CEO of Biocon. The leadership changes will be effective October 31, 2023, Biocon Biologics said in a statement.
Torrent Pharmaceutical is in preliminary talks with Apollo Global Management to secure a loan of up to $1 billion to help fund a planned bid for Cipla, Reuters reported.
"Every one of our individual businesses is at an inflection point of high growth. Peter Bains, who is a veteran when it comes to the pharma and biopharma industry in terms of his global experience, also understands the Biocon Group because he has basically played a very key role in Syngene. Through Syngene, he has understood the entire Biocon business very well."